Better Therapeutics To Become Publicly Traded Prescription Digital Therapeutics Company Via Merger With Mountain Crest Acquisition Corp. II

Better Therapeutics, Inc., a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases, will go public, raising up to $113 million to advance its robust pipeline of products. Better Therapeutics has entered into a definitive merger agreement with Mountain Crest Acquisition Corp II, a publicly traded special purpose acquisition corporation (SPAC). The transaction values Better Therapeutics at a pro forma fully diluted enterprise value of approximately $187 million with existing Better Therapeutics shareholders rolling over 100% of their equity into equity of the combined company. Upon completion of the transaction, which is anticipated . . .